Literature DB >> 15128407

Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner.

Lori-An V Etherington1, Bruno G Frenguelli.   

Abstract

The purine nucleoside adenosine is released during seizure activity and exerts an anticonvulsant influence through inhibition of glutamate release and hyperpolarization of neurons via adenosine A(1) receptors. However, activation of adenosine A(2A) and A(3) receptors may counteract the inhibitory effects of A(1) receptors. We have therefore examined the extent to which endogenous adenosine released during seizure activity activates the different adenosine receptor subtypes and the implications for seizure activity in the rat hippocampus in vitro. Brief trains of high-frequency stimulation in nominally Mg(2+)-free artificial cerebrospinal fluid evoked epileptiform activity and resulted in a transient depression of the simultaneously recorded CA1 field excitatory postsynaptic potential. In the presence of 8-cyclopentyl-1,3-dimethylxanthine (CPT), an adenosine A(1) receptor antagonist, the occurrence of spontaneous seizure activity was greatly increased as was the duration and intensity of evoked seizures, whilst the postictal depression of basal synaptic transmission was greatly attenuated. Application of ZM 241385, an adenosine A(2A) receptor antagonist, shortened the duration of epileptiform activity, whereas administration of MRS 1191, an adenosine A(3) receptor antagonist, both decreased the duration and intensity of seizures. Combined application of the A(2A) and A(3) receptor antagonists also resulted in a reduction in seizure duration and intensity. However, no evidence was found for a role for protein kinase C in the regulation of seizure activity by endogenous adenosine. Our data confirm the dominant anticonvulsant role that endogenous and tonic adenosine play via the A(1) receptor, and suggest that the additional adenosine receptor subtypes may compromise this anticonvulsant property through promotion of seizure activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128407     DOI: 10.1111/j.0953-816X.2004.03355.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  31 in total

1.  Adenosine: a fundamental factor formed from Fatty feasts for fighting fits?

Authors:  Jong M Rho
Journal:  Epilepsy Curr       Date:  2012-01       Impact factor: 7.500

2.  Purines and the Anti-Epileptic Actions of Ketogenic Diets.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin; Jeremy Gawryluk; Xuesong Chen; Jonathan D Geiger
Journal:  Open Neurosci J       Date:  2010-01-01

3.  Adenosine and ATP link PCO2 to cortical excitability via pH.

Authors:  Chris G Dulla; Peter Dobelis; Tim Pearson; Bruno G Frenguelli; Kevin J Staley; Susan A Masino
Journal:  Neuron       Date:  2005-12-22       Impact factor: 17.173

4.  Intracellular acidification causes adenosine release during states of hyperexcitability in the hippocampus.

Authors:  Chris G Dulla; Bruno G Frenguelli; Kevin J Staley; Susan A Masino
Journal:  J Neurophysiol       Date:  2009-07-22       Impact factor: 2.714

5.  Contribution of extrasynaptic N-methyl-D-aspartate and adenosine A1 receptors in the generation of dendritic glutamate-mediated plateau potentials.

Authors:  Katerina D Oikonomou; Mandakini B Singh; Matthew T Rich; Shaina M Short; Srdjan D Antic
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 6.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

Review 7.  Adenosine and autism: a spectrum of opportunities.

Authors:  Susan A Masino; Masahito Kawamura; Jessica L Cote; Rebecca B Williams; David N Ruskin
Journal:  Neuropharmacology       Date:  2012-08-24       Impact factor: 5.250

8.  Release of adenosine and ATP during ischemia and epilepsy.

Authors:  Nicholas Dale; Bruno G Frenguelli
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

9.  Adenosine and adenosine receptors: Newer therapeutic perspective.

Authors:  S Manjunath; Pranavkumar M Sakhare
Journal:  Indian J Pharmacol       Date:  2009-06       Impact factor: 1.200

10.  Activity-dependent release of adenosine: a critical re-evaluation of mechanism.

Authors:  Mark Wall; Nicholas Dale
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.